Case Report: Glioblastoma Multiforme Complicating Familial Cavernous Malformations

Overview

Journal Clin Neuroradiol

Specialties Neurology
Radiology

Date 2013 Aug 15

PMID 23942770

Citations 4

Authors

D M Wilson

B Cohen

K Keshari

H Vogel

G Steinberg

W Dillon

Affiliations

Soon will be listed here.

Citing Articles

Glioblastoma imitating a cavernoma radiologically: A unique image report.

Baqai M, Aziz H, Qazi S, Faisal K, Shah S Surg Neurol Int. 2023; 14:112.

PMID: 37151445 PMC: 10159318. DOI: 10.25259/SNI_976_2022.

Loss of programmed cell death 10 activates tumor cells and leads to temozolomide-resistance in glioblastoma.

Nickel A, Wan X, Saban D, Weng Y, Zhang S, Keyvani K J Neurooncol. 2018; 141(1):31-41.

PMID: 30392087 DOI: 10.1007/s11060-018-03017-7.

Hyperintense perilesional edema in the brain on T1-weighted images: Cavernous malformation or metastatic melanoma? Three case reports and literature review.

Sarbu N, Pujol T, Oleaga L Neuroradiol J. 2016; 29(1):52-6.

PMID: 26838172 PMC: 4978347. DOI: 10.1177/1971400915626430.

Downregulation of programmed cell death 10 is associated with tumor cell proliferation, hyperangiogenesis and peritumoral edema in human glioblastoma.

Lambertz N, El Hindy N, Kreitschmann-Andermahr I, Stein K, Dammann P, Oezkan N BMC Cancer. 2015; 15:759.

PMID: 26490252 PMC: 4618952. DOI: 10.1186/s12885-015-1709-8.

References

Wustehube J, Bartol A, Liebler S, Brutsch R, Zhu Y, Felbor U . Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling. Proc Natl Acad Sci U S A. 2010; 107(28):12640-5. PMC: 2906569. DOI: 10.1073/pnas.1000132107. View

Medici D, Shore E, Lounev V, Kaplan F, Kalluri R, Olsen B . Conversion of vascular endothelial cells into multipotent stem-like cells. Nat Med. 2010; 16(12):1400-6. PMC: 3209716. DOI: 10.1038/nm.2252. View

Chee C, Johnston R, Doyle D, Macpherson P . Oligodendroglioma and cerebral cavernous angioma. Case report. J Neurosurg. 1985; 62(1):145-7. DOI: 10.3171/jns.1985.62.1.0145. View

Palma L, Mastronardi L, Celli P, dAddetta R . Cavernous angioma associated with oligo-astrocytoma-like proliferation. Report of two cases and review of the literature with a reappraisal of the term "angioglioma". Acta Neurochir (Wien). 1995; 133(3-4):169-73. DOI: 10.1007/BF01420069. View

Kalluri R, Weinberg R . The basics of epithelial-mesenchymal transition. J Clin Invest. 2009; 119(6):1420-8. PMC: 2689101. DOI: 10.1172/JCI39104. View

Cavalcanti D, Kalani M, Martirosyan N, Eales J, Spetzler R, Preul M . Cerebral cavernous malformations: from genes to proteins to disease. J Neurosurg. 2011; 116(1):122-32. DOI: 10.3171/2011.8.JNS101241. View

Sahoo T, Johnson E, Thomas J, Kuehl P, Jones T, Dokken C . Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1). Hum Mol Genet. 1999; 8(12):2325-33. DOI: 10.1093/hmg/8.12.2325. View

Dubovsky J, Zabramski J, Kurth J, Spetzler R, Rich S, Orr H . A gene responsible for cavernous malformations of the brain maps to chromosome 7q. Hum Mol Genet. 1995; 4(3):453-8. DOI: 10.1093/hmg/4.3.453. View

Liquori C, Berg M, Siegel A, Huang E, Zawistowski J, Stoffer T . Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations. Am J Hum Genet. 2003; 73(6):1459-64. PMC: 1180409. DOI: 10.1086/380314. View

10.

Denier C, Goutagny S, Labauge P, Krivosic V, Arnoult M, Cousin A . Mutations within the MGC4607 gene cause cerebral cavernous malformations. Am J Hum Genet. 2004; 74(2):326-37. PMC: 1181930. DOI: 10.1086/381718. View

11.

Kilic T, Pamir M, Kullu S, Eren F, Ozek M, Black P . Expression of structural proteins and angiogenic factors in cerebrovascular anomalies. Neurosurgery. 2000; 46(5):1179-91; discussion 1191-2. DOI: 10.1097/00006123-200005000-00032. View

12.

Craig H, Gunel M, Cepeda O, Johnson E, Ptacek L, Steinberg G . Multilocus linkage identifies two new loci for a mendelian form of stroke, cerebral cavernous malformation, at 7p15-13 and 3q25.2-27. Hum Mol Genet. 1998; 7(12):1851-8. DOI: 10.1093/hmg/7.12.1851. View

13.

Faurobert E, Albiges-Rizo C . Recent insights into cerebral cavernous malformations: a complex jigsaw puzzle under construction. FEBS J. 2010; 277(5):1084-96. PMC: 3076058. DOI: 10.1111/j.1742-4658.2009.07537.x. View

14.

Labauge P, Brunereau L, Levy C, Laberge S, Houtteville J . The natural history of familial cerebral cavernomas: a retrospective MRI study of 40 patients. Neuroradiology. 2000; 42(5):327-32. DOI: 10.1007/s002340050893. View

15.

Robinson J, Awad I, Little J . Natural history of the cavernous angioma. J Neurosurg. 1991; 75(5):709-14. DOI: 10.3171/jns.1991.75.5.0709. View

16.

Saito A . EMT and EndMT: regulated in similar ways?. J Biochem. 2013; 153(6):493-5. DOI: 10.1093/jb/mvt032. View

17.

Fischer E, Sotrel A, Welch K . Cerebral hemangioma with glial neoplasia (angioglioma?). Report of two cases. J Neurosurg. 1982; 56(3):430-4. DOI: 10.3171/jns.1982.56.3.0430. View

18.

Maddaluno L, Rudini N, Cuttano R, Bravi L, Giampietro C, Corada M . EndMT contributes to the onset and progression of cerebral cavernous malformations. Nature. 2013; 498(7455):492-6. DOI: 10.1038/nature12207. View

19.

de Champfleur N, Langlois C, Ankenbrandt W, Le Bars E, Leroy M, Duffau H . Magnetic resonance imaging evaluation of cerebral cavernous malformations with susceptibility-weighted imaging. Neurosurgery. 2010; 68(3):641-7. DOI: 10.1227/NEU.0b013e31820773cf. View

20.

Mian M, Nahed B, Walcott B, Ogilvy C, Curry W . Glioblastoma multiforme and cerebral cavernous malformations: intersection of pathophysiologic pathways. J Clin Neurosci. 2011; 19(6):884-6. DOI: 10.1016/j.jocn.2011.07.017. View